A lawsuit where a biotech company tries to defend their proprietary extracting technology could set an important new precedent.
In this series, we sit down with experts from A2LA to learn about cannabis lab accreditation.
ACT Labs and Keystone State Testing are the first two labs to gain approval.
G3 Labs had their license suspended due to an undisclosed compliance issue.
The advisory was issued after authorities detected the presence of Avermectin, an insecticide not approved for use on cannabis.
The rule change requires manufacturers to ditch animal, human or fruit-shaped edibles and use non-descript shapes instead.
The Emerald Test is now officially approved as a component of cannabis lab licensing in Colorado and Washington.
CIJ’s Brian Blumenfeld continues the series on federal legislation with a review of the medical cannabis reform bills in Congress.
We sit down with Josh Drayton, deputy director of the CCIA, to chat about the upcoming changes in the CA cannabis regulatory environment.
Random sampling and testing by Health Canada detected myclobutanil and spinosad in three lots of cannabis.